MX2010001145A - Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. - Google Patents

Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.

Info

Publication number
MX2010001145A
MX2010001145A MX2010001145A MX2010001145A MX2010001145A MX 2010001145 A MX2010001145 A MX 2010001145A MX 2010001145 A MX2010001145 A MX 2010001145A MX 2010001145 A MX2010001145 A MX 2010001145A MX 2010001145 A MX2010001145 A MX 2010001145A
Authority
MX
Mexico
Prior art keywords
treatment
compound
articular
skin
blood
Prior art date
Application number
MX2010001145A
Other languages
English (en)
Inventor
Aldecoa Eduardo Anitua
Alvarez Mikel Sanchez
Original Assignee
Biotechnology Inst I Mas D Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Inst I Mas D Sl filed Critical Biotechnology Inst I Mas D Sl
Publication of MX2010001145A publication Critical patent/MX2010001145A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Método para el tratamiento de dolencias o enfermedades articulares o para el tratamiento de la piel, que comprende la infiltración o la aplicación de un compuesto que comprende al menos una sustancia derivada de sangre, la cual es preferentemente un plasma sanguíneo en general, y en particular un plasma rico en plaquetas (PRP), prefiriéndose entre los, compuestos PRP un plasma rico en factores de crecimiento (PRGF), y/o un sobrenadante de cualquiera de los plasmas anteriores. El método según la invención permite aliviar e incluso regenerar las zonas tratadas de forma notable. Opcionalmente, la sustancia derivada de sangre podrá mezclarse con ácido hialurónico (HA) y/o un compuesto derivado de HA, consiguiéndose efectos aún más beneficiosos.
MX2010001145A 2007-08-02 2008-07-17 Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. MX2010001145A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200702174A ES2333498B1 (es) 2007-08-02 2007-08-02 Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.
PCT/IB2008/001916 WO2009016451A2 (en) 2007-08-02 2008-07-17 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound

Publications (1)

Publication Number Publication Date
MX2010001145A true MX2010001145A (es) 2010-03-01

Family

ID=40154982

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001145A MX2010001145A (es) 2007-08-02 2008-07-17 Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.

Country Status (14)

Country Link
US (1) US20090035382A1 (es)
EP (1) EP2185163A2 (es)
JP (1) JP2010535188A (es)
KR (1) KR20100075827A (es)
CN (1) CN101842104A (es)
AR (1) AR067794A1 (es)
BR (1) BRPI0813192A2 (es)
CA (1) CA2695398A1 (es)
CL (1) CL2008002089A1 (es)
CO (1) CO6251373A2 (es)
ES (1) ES2333498B1 (es)
MX (1) MX2010001145A (es)
RU (1) RU2010107463A (es)
WO (1) WO2009016451A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
KR101114712B1 (ko) 2009-10-23 2012-02-29 세원셀론텍(주) 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
GB201004072D0 (en) * 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
RU2455028C1 (ru) * 2010-12-22 2012-07-10 Федеральное государственное учреждение "Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова Минздравсоцразвития России" Способ лечения остеоартроза коленного сустава
KR101038616B1 (ko) * 2011-03-16 2011-06-03 박재우 뼈 및 연골 질환의 치료, 예방, 또는 완화용 약제학적 조성물
ES2414306B1 (es) * 2012-01-13 2014-05-21 Salserret, S.L. Composición para la eliminación o atenuación de estrías
DK2628484T3 (en) * 2012-02-17 2016-08-01 Opko Lab Europe Sl Trombocytrige plasma compositions
RU2491964C1 (ru) * 2012-05-24 2013-09-10 Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова Министерства здравоохранения и социального развития Российской Федерации" Способ консервативного лечения эпикондилита плеча
RU2495638C1 (ru) * 2012-07-12 2013-10-20 федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт травматологии и ортопедии имени Н.Н. Приорова" Министерства здравоохранения Российской Федерации Способ стимуляции дистракционного замедленно созревающего регенерата трубчатых костей
ES2442242B1 (es) * 2012-08-09 2014-11-25 Biotechnology Institute, I Mas D, S.L. Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.
CN104703612B (zh) * 2012-09-26 2021-03-19 骨治疗公司 包含溶剂/去污剂处理过的血浆(s/d血浆)的制剂及其用途
ES2527967B1 (es) * 2013-08-01 2015-12-28 Biotechnology Institute, I Mas D, S.L. Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma
US20160367474A1 (en) * 2015-06-17 2016-12-22 Anthony Pignataro Treatment process for skin imperfections
CN106727244A (zh) * 2017-01-10 2017-05-31 成都中科同体生物医学研究院 同体生物微球及用于注射该微球的注射器
CN108310013A (zh) * 2018-03-12 2018-07-24 远助同成医疗科技（北京）有限公司 一种用于治疗关节炎的复合物及其制备方法
IT201800010415A1 (it) * 2018-11-19 2020-05-19 Innate S R L Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
US20220088589A1 (en) 2019-01-21 2022-03-24 Eclipse Medcorp, Llc Methods, Systems and Apparatus for Separating Components of a Biological Sample
PT3996673T (pt) 2019-07-08 2023-10-24 Theravet Sa Um método para a preparação de uma composição de formação de gel
WO2021005071A1 (en) 2019-07-08 2021-01-14 Theravet Sa A composition, a kit and use thereof
US20220193128A1 (en) * 2019-07-08 2022-06-23 Theravet Sa A composition, a kit and use thereof
RU2703821C1 (ru) * 2019-07-26 2019-10-22 Карен Альбертович Егиазарян Способ лечения остеоартроза коленного сустава
KR20220091580A (ko) 2019-10-31 2022-06-30 이클립스 메드코프 엘엘씨 샘플의 구성요소들을 분리하기 위한 시스템, 방법 및 장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645945B1 (en) 1996-03-05 2003-11-11 Depuy Acromed, Inc. Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors
AR022333A1 (es) 1999-01-26 2002-09-04 Anitua Aldecoa Eduardo Regenerador de tejido oseo
BR0112109A (pt) * 2000-06-29 2007-05-29 Biosyntech Canada Inc composição e método para a correção e regeneração de cartilagem e outros tecidos
ES2180438B2 (es) 2001-06-13 2004-11-01 Eduardo Anitua Aldecoa Disposicion para constituir una superficie bioactiva en implantes o protesis.
US6924273B2 (en) 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
DE10054257A1 (de) * 2000-11-02 2002-05-16 Kief Horst Heilmittel zur Intraarticulären Injektion
ES2221770B2 (es) * 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
TW583677B (en) 2002-07-25 2004-04-11 Ememory Technology Inc Flash memory with sensing amplifier using load transistors driven by coupled gate voltages
US8052969B2 (en) * 2006-12-28 2011-11-08 Arthrex, Inc. Method of making plasma enriched with platelets using a double syringe system where the second sytringe is within the first syringe and use thereof

Also Published As

Publication number Publication date
WO2009016451A2 (en) 2009-02-05
WO2009016451A9 (en) 2010-04-01
ES2333498B1 (es) 2011-01-10
AR067794A1 (es) 2009-10-21
CN101842104A (zh) 2010-09-22
WO2009016451A3 (en) 2009-03-26
JP2010535188A (ja) 2010-11-18
US20090035382A1 (en) 2009-02-05
CL2008002089A1 (es) 2009-06-12
EP2185163A2 (en) 2010-05-19
CA2695398A1 (en) 2009-02-05
KR20100075827A (ko) 2010-07-05
WO2009016451A8 (en) 2010-02-18
RU2010107463A (ru) 2011-09-10
CO6251373A2 (es) 2011-02-21
ES2333498A1 (es) 2010-02-22
BRPI0813192A2 (pt) 2015-09-29

Similar Documents

Publication Publication Date Title
MX2010001145A (es) Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.
WO2006127007A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
WO2010065671A3 (en) Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
WO2009038720A3 (en) Method and apparatus for applying light therapy
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MX2010004074A (es) Combinacion 059.
AU2011328009A8 (en) Compounds and methods for treating pain
TW200637574A (en) Treatment method
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2009081408A3 (en) Pulverized fibrin clots and pharmaceutical compositions containing them
WO2007070637A3 (en) Method of treating open wounds using hypochlorous acid
EA201001749A1 (ru) Способ лечения недифференцированного артрита
WO2007092796A3 (en) Galvanic current skin treatment
RU2013132566A (ru) Терапевтическое средство от грыжи межпозвоночного диска
WO2006084153A3 (en) Methods and materials with trans-clomiphene for the treatment of male infertility
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2010037864A3 (en) Inhibition of plgf to treat philadelphia chromosome positive leukemia
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
WO2009105507A3 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
TW200603792A (en) Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
WO2009022179A3 (en) Glucokinase activators in the treatment of osteoarthritis
WO2009134396A3 (en) Use of corticotropin-releasing factor for the treatment of cancer
UA97875C2 (ru) Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы на основе стефаглабрина
MD2666F1 (en) Method of treatment of chronic recidivating bursitis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal